Alnylam Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Period Activity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Alnylam Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Period Activity

Alnylam Pharma (ALNY) Tops Q2 EPS by 7c

August 6, 2020 8:03 AM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of ($1.67), $0.07 better than the analyst estimate of ($1.74). Revenue for the quarter came in at $104 million versus the consensus estimate of $99.48 million.

2020 Outlook*

Reflecting our first-half results and our current market expectations for the balance of the year, and subject to... More